Dr. Yashwant Kumar Ratre is a dedicated cancer researcher committed to exploring the molecular and metabolic mechanisms underlying cancer progression. His expertise spans glutamine metabolism, chemoresistance, and cancer stemness, with a focus on leveraging these insights to develop innovative therapies. Dr. Ratre's academic journey includes a Ph.D. in Biotechnology, during which he investigated metabolic alterations in breast cancer, and an M.Sc. in Medical Biotechnology, where he examined genetic polymorphisms associated with cervical cancer. With a prolific research portfolio, he has contributed extensively to high-impact journals, presenting work on metabolic reprogramming, drug resistance, and cancer therapeutics. Dr. Ratre also brings robust experience in interdisciplinary collaboration, integrating bioinformatics, molecular biology, and clinical studies to advance translational research. His dedication to advancing cancer care reflects his passion for improving patient outcomes through innovative science.